M&A

As its slide stretches into a second year, Zymeworks faces takeover bid
Endpoints
Fri, 04/29/22 - 10:43 am
Zymeworks
M&A
All Blue Falcons
With a buyout, planned spinout and late-stage readouts, GSK promises this will be a landmark year
Endpoints
Wed, 04/27/22 - 10:42 pm
GSK
earnings
M&A
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics
Fierce Biotech
Wed, 04/27/22 - 10:40 am
Caladrius Biosciences
Cend Therapeutics
M&A
solid tumors
Lisata Therapeutics
Novartis confirms 'thousands' of layoffs loom as its global reorganization rolls ahead
Fierce Pharma
Tue, 04/26/22 - 10:38 pm
Novartis
layoffs
M&A
Biotechs Turn to M&A as Liquidity Surges and Market Caps Falter
BioSpace
Mon, 04/25/22 - 10:44 am
biotech
M&A
biotech stocks
Sanofi's latest analysis of Rezurock can inform future research, company says
Fierce Pharma
Thu, 04/21/22 - 10:34 am
Sanofi
Kadmon
M&A
graft vs host disease
Rezurock
J&J Medtech Execs Say Strategic Merit, Not Size, Matters in M&A
Medical Devices and Diagnostics Industry
Wed, 04/20/22 - 11:05 am
JNJ
Medtech
devices
earnings
M&A
Thread builds in decentralized trials again with CureClick buy
Pharmaforum
Wed, 04/20/22 - 10:46 am
decentralized clinical trials
clinical trials
Thread
CureClick
M&A
machine learning
artificial intelligence
Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition
Fierce Biotech
Tue, 04/19/22 - 11:10 am
Regeneron
Checkmate Pharmaceuticals
M&A
skin cancer
vidutolimod
Acadia's prized pain drug from $52M buyout flops its first test
Endpoints
Tue, 04/19/22 - 10:57 am
Acadia Pharmaceuticals
CerSci Therapeutics
M&A
ACP-044
non-opioid pain treatments
Here’s How Pfizer Is Boldly Moving into Digital Health
Medical Devices and Diagnostics Industry
Thu, 04/14/22 - 11:00 am
Pfizer
digital health
M&A
ResApp Health
Medtech
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
M&A
AbbVie
Biocon
Biogen
Biohaven
GSK
Halozyme Therapeutics
Samsung Bioepis
UCB
Viatris
GSK to buy Sierra Oncology amid pressure to boost drug pipeline
Reuters
Wed, 04/13/22 - 05:39 pm
GSK
Sierra Oncology
M&A
Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B
BioSpace
Wed, 04/13/22 - 10:53 am
Halozyme Therapeutics
Antares Pharma
M&A
drug delivery
Medtech
Pfizer to drop $74M for COVID cough-screening smartphone app developer
Fierce Biotech
Mon, 04/11/22 - 07:35 pm
Pfizer
ResApp Health
COVID-19
Medtech
diagnostics
M&A
mobile apps
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Fierce Biotech
Thu, 04/7/22 - 10:29 am
Pfizer
RSV
M&A
ReViral
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Merck cuts 170 jobs at Acceleron right on heels of $11.5B buyout
Fierce Pharma
Wed, 03/30/22 - 11:05 am
Merck
Acceleron
M&A
layoffs
Cambridge
Eagle Announces Acquisition of Acacia in Strategic Good Fit
BioSpace
Mon, 03/28/22 - 10:11 am
Acacia Pharma
Eagle Pharmaceuticals
M&A
Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
Fierce Pharma
Thu, 03/24/22 - 08:40 pm
Sun Pharma
legal
Ranbaxy
M&A

Pages